Preliminary program, to be continually updated.

Thursday 21 May

11:30-13:00 Registration

12:00-13:00 Lunch symposium – TBN

13:00-13:10 Opening and welcome remarks – Åke Sjöholm (SE)

13:10-13:55 Keynote lecture: Incretin therapy of obesity and diabetes – Jens J. Holst (DK)
                       Chair: Åke Sjöholm (SE)

13:55-14:15 Coffee and visit to exhibition

14:15-15:00 Barndiabetesfondens Johnny Ludvigsson Nordic Prize: Early signs of type 1 diabetes – Riitta Lahesmaa (FIN)
                        Chair: Johnny Ludvigsson (SE)

15:00-15:30 Barndiabetesfondens Young Swedish Investigator Prize:                              
                       Investigations of local immune regulatory mechanisms in type 1 diabetes – Gustaf Christoffersson (SE)

15:30-16:30 Abstract session #1 – TBN
                        Chair: TBN

16:30-17:15 Keynote lecture: GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity – Tore Bengtsson (SE)
                       Chair: Åke Sjöholm (SE)

17:15-18:15  Novo Nordisk Foundation Nordic Diabetes Prize – TBN
                       Chair: TBN

19:30-         Welcome Reception

Friday 22 May

08:00-08:45 Knud Lundbæk Award – TBN
                          Chair: TBN

08:45-09:30 Keynote lecture: Factors affecting the progression rate from seroconversion to autoantibody
                         positivity to clinical type 1 diabetes – Mikael Knip (FIN)
                          Chair: TBN

09:30-10:30 Abstract session #2 – TBN
                          Chair: TBN

10:30-10:50 Coffee and visit to exhibition

10:50-11:35 Keynote lecture: Exercise timing and circadian regulation of metabolism in type 2 diabetes – Harriet Wallberg (SE)
                        Chair: TBN

11:35-12:20 Keynote lecture: The insulin-resistant brain – Martin Heni (DE)
                       Chair: Åke Sjöholm

12:20-13:20 Lunch symposium – TBN

13:20-14:05 Keynote lecture: Advances in oligogenic diabetes – Amélie Bonnefond (FR)
                        Chair: TBN

14:05-14:50 Keynote lecture: Advances in diabetic nephropathy – Peter Rossing (DK) – Online presentation.
                        Chair: TBN

14:50-15:20 SSSD Young Investigator Award – TBN
                        Chair: TBN

15:20-16:05 Keynote lecture: Glucokinase as a therapeutic target in diabetes – Elaine Chow (HK)
                        Chair: TBN

16:05-16:50 Keynote lecture: Diabetes technology: Sensors and pumps – Jarl Hellman (SE)
Chair: TBN

16:50-17:10 Coffee and visit to exhibition

17:10-17:55 Keynote lecture: Lipodystrophies and the road to diabetes – Fredrik Karpe (UK)
                       Chair: TBN

17:55-18:55 Abstract session #3 – TBN
                        Chair: TBN

19:30 –         Congress dinner

Saturday 23 May

08:00-08:30 General assembly of the SSSD

08:30-09:15 Keynote lecture: Mechanisms of exocytosis in pancreatic islet cells – Patrik Rorsman (UK)
                          Chair: TBN

09:15-10:00 Keynote lecture: Mechanistic insights and approaches for β-cell regeneration – Olov Andersson (SE)
                          Chair: TBN

10:00-10:45 Keynote lecture: Survival of transplanted allogeneic β-cells with no immunosuppression – Per-Ola Carlsson (SE)
                         Chair: TBN

10:45-11:05 Coffee and visit to exhibition

11:05-11:50 Keynote lecture: Is type 1 diabetes an inflammatory pancreatic disease with its main clinical
                      symptoms due to the loss of the β-cells? – Olle Korsgren (SE)
                       Chair: TBN

11:55-12:55 Abstract session #4 – TBN
                       Chair: TBN

13:00-         Closning remarks and departure lunch – Chair of local organizing committee: Åke Sjöholm (SE)